Millennium Management’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-6,702
| Closed | -$22.8K | – | 4127 |
|
2023
Q2 | $22.8K | Sell |
6,702
-6,358
| -49% | -$21.6K | ﹤0.01% | 4038 |
|
2023
Q1 | $47K | Buy |
13,060
+10,306
| +374% | +$37.1K | ﹤0.01% | 4216 |
|
2022
Q4 | $27K | Buy |
2,754
+877
| +47% | +$8.6K | ﹤0.01% | 4564 |
|
2022
Q3 | $24K | Buy |
1,877
+1,163
| +163% | +$14.9K | ﹤0.01% | 4945 |
|
2022
Q2 | $14K | Buy |
+714
| New | +$14K | ﹤0.01% | 4968 |
|
2021
Q4 | – | Sell |
-764
| Closed | -$25K | – | 5130 |
|
2021
Q3 | $25K | Buy |
+764
| New | +$25K | ﹤0.01% | 5028 |
|
2020
Q3 | – | Sell |
-1,355
| Closed | -$59K | – | 3572 |
|
2020
Q2 | $59K | Buy |
+1,355
| New | +$59K | ﹤0.01% | 3305 |
|
2019
Q1 | – | Sell |
-1,370
| Closed | -$43K | – | 3403 |
|
2018
Q4 | $43K | Buy |
1,370
+5
| +0.4% | +$157 | ﹤0.01% | 3236 |
|
2018
Q3 | $70K | Sell |
1,365
-402
| -23% | -$20.6K | ﹤0.01% | 3382 |
|
2018
Q2 | $69K | Sell |
1,767
-6,764
| -79% | -$264K | ﹤0.01% | 3309 |
|
2018
Q1 | $311K | Sell |
8,531
-4,470
| -34% | -$163K | ﹤0.01% | 2967 |
|
2017
Q4 | $1.13M | Buy |
13,001
+7,224
| +125% | +$626K | ﹤0.01% | 2440 |
|
2017
Q3 | $709K | Sell |
5,777
-4,929
| -46% | -$605K | ﹤0.01% | 2438 |
|
2017
Q2 | $987K | Buy |
+10,706
| New | +$987K | ﹤0.01% | 2236 |
|
2016
Q1 | – | Sell |
-2,561
| Closed | -$743K | – | 2985 |
|
2015
Q4 | $743K | Sell |
2,561
-536
| -17% | -$156K | ﹤0.01% | 2248 |
|
2015
Q3 | $1.49M | Buy |
+3,097
| New | +$1.49M | ﹤0.01% | 1920 |
|